Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern.
about
In Hot Pursuit of the First Vaccine Against Respiratory Syncytial VirusBrief History and Characterization of Enhanced Respiratory Syncytial Virus DiseaseWanted, dead or alive: New viral vaccinesA De-O-acylated Lipooligosaccharide-Based Adjuvant System Promotes Antibody and Th1-Type Immune Responses to H1N1 Pandemic Influenza Vaccine in MicePulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease.Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced diseaseThe number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG.Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.Intranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategiesIntranasal antibody prophylaxis for protection against viral disease.Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challengeCytotoxic T-lymphocyte precursor frequencies in BALB/c mice after acute respiratory syncytial virus (RSV) infection or immunization with a formalin-inactivated RSV vaccineRespiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.Epitope mapping and kinetics of CD4 T cell immunity to pneumonia virus of mice in the C57BL/6 strain.Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse.Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism.Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge.Differential histopathology and chemokine gene expression in lung tissues following respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV- or BBG2Na-immunized mice.Production of antibodies with peptide-CpG-DNA-liposome complex without carriers.Immune responses and disease enhancement during respiratory syncytial virus infectionRespiratory syncytial virus vaccinesImmunoprotectivity of HLA-A2 CTL peptides derived from respiratory syncytial virus fusion protein in HLA-A2 transgenic mouseGene expression differences in lungs of mice during secondary immune responses to respiratory syncytial virus infection.Prophylactic treatment with a G glycoprotein monoclonal antibody reduces pulmonary inflammation in respiratory syncytial virus (RSV)-challenged naive and formalin-inactivated RSV-immunized BALB/c mice.Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis.Immunoprotective activity and safety of a respiratory syncytial virus vaccine: mucosal delivery of fusion glycoprotein with a CpG oligodeoxynucleotide adjuvant.Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vectorGamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragmentImmunization of macaques with formalin-inactivated respiratory syncytial virus (RSV) induces interleukin-13-associated hypersensitivity to subsequent RSV infectionGinseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses.Identification of immunodominant epitopes derived from the respiratory syncytial virus fusion protein that are recognized by human CD4 T cells.The use of a neonatal mouse model to study respiratory syncytial virus infections.Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteinsEvaluation of an intranasal virosomal vaccine against respiratory syncytial virus in mice: effect of TLR2 and NOD2 ligands on induction of systemic and mucosal immune responses.Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles.Prior exposure to live Mycobacterium bovis BCG decreases Cryptococcus neoformans-induced lung eosinophilia in a gamma interferon-dependent mannerEffects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV.
P2860
Q26748856-BABC7702-553F-49D4-A70E-FBB451B9BB92Q26775152-BF39E1A5-7678-473C-85E5-7276E463BC05Q27489979-EE89556B-FD15-43DF-B3E6-2F897F92B68CQ30395705-63C81541-AC12-4BCC-BEA2-31503815A022Q30435871-7DBB71CE-7BB6-476A-9549-21578054F08AQ30436942-765E5081-CC02-4AA5-88D6-B71B9B34C9C5Q30437797-2B4D9813-D2FB-4DCF-AE0E-674B8E1FC766Q30485791-F051FD45-12A4-44B2-9E98-FB5DCF20A5A9Q33558475-5A016132-1157-4659-B9D0-52090C99C156Q33613442-AE0CD43F-B57D-49FC-834E-4882038DED0EQ33683058-22A1832A-309F-4DC4-860F-FBE472C1AD39Q33783066-BAC41754-FCF7-4FB4-BADC-83BF91711CB5Q33785332-584C50F2-E25F-482D-B71E-318175BC0D07Q33797058-2834BC06-7F25-4C05-A434-F195B0D8E009Q33799416-ADA1D74F-1D8A-46E7-93BF-5C943B34074FQ33807265-0611317F-2C44-4C69-88E9-4C53E16A9F53Q33820420-905A3C34-23B3-4529-ACDA-137A949DB90AQ33849224-510C7E26-B85A-4B8E-A56E-650790237602Q33870528-BC978A6C-1B0E-4F0A-B8E1-3ABD286885D8Q33904706-5BFEEB3F-8071-4703-A189-A2BB2D7ECE99Q33937152-2A398E17-D07B-48D5-90CE-A5FD2A17EB12Q33975330-3A410527-2C6C-4425-875D-62A02522E4FEQ34043293-F711AC2A-0720-4C65-A388-CC761FC9BD5CQ34120191-A5BAE498-E62E-400B-BA70-C0ACF4EAF8B7Q34120278-85D5B5F9-6458-44F9-AD94-696ED32EB781Q34224973-72466ACF-B05C-496D-AEA2-6B6A90678D10Q34226850-F2ED7E35-22D2-4DBC-930C-6DC4AAA43008Q34247261-610BBCFD-1C41-4115-B892-5AC858A5C243Q34302198-2FEDB06E-D4EC-4FAB-9F5A-042DA2E15490Q34347904-01B01CE4-7AC6-4AD8-A018-0890F6E7B627Q34355131-A786A17F-2821-43D4-9EAB-6FE64D203644Q34440116-21894CDA-D27B-49A7-8D6C-F36F3167A65CQ34465367-F6225F81-ED17-49EC-A8A0-02ADBC0773BBQ34549253-79D047BF-9B92-4F0D-AB71-3B08949310E1Q34616642-97D5C482-355A-451C-AE84-255F36B99E59Q34674831-6B2782AC-BA00-421A-9339-96E4278EECBCQ34791209-560041D3-03AC-4BE4-B88F-AA924BEDF467Q34948645-C2DD2A28-54A6-4362-A003-1789538262E4Q35011426-2E8B6064-CBD2-4658-A937-96E71D3D4729Q35063967-8266469B-14F7-4D48-A4CF-1524188A0E20
P2860
Respiratory synctial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Respiratory synctial virus inf ...... ant Th2-like cytokine pattern.
@ast
Respiratory synctial virus inf ...... ant Th2-like cytokine pattern.
@en
type
label
Respiratory synctial virus inf ...... ant Th2-like cytokine pattern.
@ast
Respiratory synctial virus inf ...... ant Th2-like cytokine pattern.
@en
prefLabel
Respiratory synctial virus inf ...... ant Th2-like cytokine pattern.
@ast
Respiratory synctial virus inf ...... ant Th2-like cytokine pattern.
@en
P2093
P2860
P1433
P1476
Respiratory synctial virus inf ...... ant Th2-like cytokine pattern.
@en
P2093
P2860
P304
P407
P577
1996-05-01T00:00:00Z